{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T04:25:59Z","timestamp":1790223959448,"version":"4.1.0"},"reference-count":35,"publisher":"Elsevier BV","content-domain":{"domain":["jad-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Affective Disorders"],"published-print":{"date-parts":[[2014,4]]},"DOI":"10.1016\/j.jad.2014.02.017","type":"journal-article","created":{"date-parts":[[2014,2,18]],"date-time":"2014-02-18T13:32:37Z","timestamp":1392730357000},"page":"56-61","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":265,"special_numbering":"C","title":["Do the dissociative side effects of ketamine mediate its antidepressant effects?"],"prefix":"10.1016","volume":"159","author":[{"given":"David A.","family":"Luckenbaugh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark J.","family":"Niciu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dawn F.","family":"Ionescu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neal M.","family":"Nolan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erica M.","family":"Richards","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nancy E.","family":"Brutsche","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Guevara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlos A.","family":"Zarate","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jad.2014.02.017_bib1","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1007\/s00213-002-1236-6","article-title":"Ketamine does not decrease striatal dopamine D2 receptor binding in man","volume":"164","author":"Aalto","year":"2002","journal-title":"Psychopharmacol. (Berl.)"},{"key":"10.1016\/j.jad.2014.02.017_bib2","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1007\/s00213-005-0092-6","article-title":"Cortical glutamate\u2013dopamine interaction and ketamine-induced psychotic symptoms in man","volume":"182","author":"Aalto","year":"2005","journal-title":"Psychopharmacol. (Berl.)"},{"key":"10.1016\/j.jad.2014.02.017_bib3","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.biopsych.2009.08.038","article-title":"Safety and efficacy of repeated-dose intravenous ketamine for treatment-resistant depression","volume":"67","author":"aan het Rot","year":"2010","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.jad.2014.02.017_bib4","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/j.biopsych.2012.05.003","article-title":"Ketamine for depression: where do we go from here?","volume":"72","author":"Aan Het Rot","year":"2012","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.jad.2014.02.017_bib5","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1002\/syn.1114","article-title":"NMDA antagonist effects on striatal dopamine release: microdialysis studies in awake monkeys","volume":"43","author":"Adams","year":"2002","journal-title":"Synapse"},{"key":"10.1016\/j.jad.2014.02.017_bib6","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1001\/archpsyc.57.3.270","article-title":"Attenuation of the neuropsychiatric effects of ketamine with lamotrigine: support for hyperglutamatergic effects of N-methyl-d-aspartate receptor antagonists","volume":"57","author":"Anand","year":"2000","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.jad.2014.02.017_bib7","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/S0006-3223(99)00230-9","article-title":"Antidepressant effects of ketamine in depressed patients","volume":"47","author":"Berman","year":"2000","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.jad.2014.02.017_bib8","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1002\/(SICI)1098-2396(199806)29:2<142::AID-SYN5>3.0.CO;2-7","article-title":"Effects of NMDA antagonism on striatal dopamine release in healthy subjects: application of a novel PET approach","volume":"29","author":"Breier","year":"1998","journal-title":"Synapse"},{"key":"10.1016\/j.jad.2014.02.017_bib9","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1023\/A:1024465317902","article-title":"Measurement of dissociative states with the Clinician-Administered Dissociative States Scale (CADSS)","volume":"11","author":"Bremner","year":"1998","journal-title":"J Trauma. Stress"},{"key":"10.1016\/j.jad.2014.02.017_bib10","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1001\/archgenpsychiatry.2010.90","article-title":"A randomized add-on trial of an N-methyl-d-aspartate antagonist in treatment-resistant bipolar depression","volume":"67","author":"Diazgranados","year":"2010","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.jad.2014.02.017_bib11","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1038\/mp.2012.194","article-title":"Relationship of resting brain hyperconnectivity and schizophrenia-like symptoms produced by the NMDA receptor antagonist ketamine in humans","volume":"18","author":"Driesen","year":"2013","journal-title":"Mol. Psychiatry."},{"key":"10.1016\/j.jad.2014.02.017_bib12","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1016\/j.biopsych.2012.11.011","article-title":"Activation of mammalian target of rapamycin and synaptogenesis: role in the actions of rapid-acting antidepressants","volume":"73","author":"Dwyer","year":"2013","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.jad.2014.02.017_bib13","unstructured":"First, M., Spitzer R.L., Gibbon M, Williams J.B.W., 2002. Structured Clinical Interview for the DSM-IV-TR Axis I Disorders-Patient Edition. Biometrics Research Department, New York State Psychiatric Institute, New York."},{"key":"10.1016\/j.jad.2014.02.017_bib14","first-page":"166","article-title":"Initial experiences with ketamine anaesthesia","volume":"72","author":"Gibbs","year":"1970","journal-title":"N. Z. Med. J."},{"key":"10.1016\/j.jad.2014.02.017_bib15","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1016\/S0196-0644(05)82569-7","article-title":"Ketamine sedation for pediatric procedures: part 2, review and implications","volume":"19","author":"Green","year":"1990","journal-title":"Ann. Emerg. Med."},{"key":"10.1016\/j.jad.2014.02.017_bib16","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1136\/jnnp.23.1.56","article-title":"A rating scale for depression","volume":"23","author":"Hamilton","year":"1960","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.jad.2014.02.017_bib17","first-page":"21","article-title":"Rating depressive patients","volume":"41","author":"Hamilton","year":"1980","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.jad.2014.02.017_bib18","doi-asserted-by":"crossref","first-page":"1526","DOI":"10.1038\/npp.2011.338","article-title":"Course of improvement in depressive symptoms to a single intravenous infusion of ketamine vs add-on riluzole: results from a 4-week, double-blind, placebo-controlled study","volume":"37","author":"Ibrahim","year":"2012","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.jad.2014.02.017_bib19","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1002\/syn.10010","article-title":"NMDA antagonist effects on striatal dopamine release: positron emission tomography studies in humans","volume":"43","author":"Kegeles","year":"2002","journal-title":"Synapse"},{"key":"10.1016\/j.jad.2014.02.017_bib20","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1001\/archpsyc.1994.03950030035004","article-title":"Subanesthetic effects of the noncompetitive NMDA antagonist, ketamine, in humans. Psychotomimetic, perceptual, cognitive, and neuroendocrine responses","volume":"51","author":"Krystal","year":"1994","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.jad.2014.02.017_bib21","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/j.biopsych.2007.05.028","article-title":"Cellular mechanisms underlying the antidepressant effects of ketamine: role of alpha-amino-3-hydroxy-5-methylisoxazole-4-propionic acid receptors","volume":"63","author":"Maeng","year":"2008","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.jad.2014.02.017_bib22","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1017\/S1461145709000169","article-title":"Riluzole for relapse prevention following intravenous ketamine in treatment-resistant depression: a pilot randomized, placebo-controlled continuation trial","volume":"13","author":"Mathew","year":"2010","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"10.1016\/j.jad.2014.02.017_bib23","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1176\/appi.neuropsych.22.4.442","article-title":"The use of a series of ketamine infusions in two patients with treatment-resistant depression","volume":"22","author":"Messer","year":"2010","journal-title":"J. Neuropsychiatry Clin. Neurosci."},{"key":"10.1016\/j.jad.2014.02.017_bib24","doi-asserted-by":"crossref","first-page":"2921","DOI":"10.1523\/JNEUROSCI.17-08-02921.1997","article-title":"Activation of glutamatergic neurotransmission by ketamine: a novel step in the pathway from NMDA receptor blockade to dopaminergic and cognitive disruptions associated with the prefrontal cortex","volume":"17","author":"Moghaddam","year":"1997","journal-title":"J. Neurosci."},{"key":"10.1016\/j.jad.2014.02.017_bib25","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1176\/appi.ajp.2013.13030392","article-title":"Antidepressant efficacy of ketamine in treatment-resistant major depression: a two-site randomized controlled trial","volume":"170","author":"Murrough","year":"2013","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.jad.2014.02.017_bib26","doi-asserted-by":"crossref","first-page":"799","DOI":"10.2466\/pr0.1962.10.3.799","article-title":"The brief psychiatric rating scale","volume":"10","author":"Overall","year":"1962","journal-title":"Psychol. Rep."},{"key":"10.1016\/j.jad.2014.02.017_bib27","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1097\/JCP.0b013e31818a6cea","article-title":"An innovative design to establish proof of concept of the antidepressant effects of the NR2B subunit selective N-methyl-d-aspartate antagonist, CP-101,606, in patients with treatment-refractory major depressive disorder","volume":"28","author":"Preskorn","year":"2008","journal-title":"J. Clin. Psychopharmacol."},{"key":"10.1016\/j.jad.2014.02.017_bib28","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/S0893-133X(97)00092-4","article-title":"Glutamate modulation of dopamine measured in vivo with positron emission tomography (PET) and 11C-raclopride in normal human subjects","volume":"18","author":"Smith","year":"1998","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.jad.2014.02.017_bib29","first-page":"287","article-title":"Relationship of ketamine\u05f3s antidepressant and psychotomimetic effects in unipolar depression","volume":"34","author":"Sos","year":"2013","journal-title":"Neuroendocrinol. Lett."},{"key":"10.1016\/j.jad.2014.02.017_bib30","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.pscychresns.2010.10.009","article-title":"The antidepressant effect of ketamine is not associated with changes in occipital amino acid neurotransmitter content as measured by [(1)H]-MRS","volume":"191","author":"Valentine","year":"2011","journal-title":"Psychiatry Res."},{"key":"10.1016\/j.jad.2014.02.017_bib31","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1017\/S1461145712000764","article-title":"Vulnerability to psychotogenic effects of ketamine is associated with elevated D(2\/3)-receptor availability","volume":"16","author":"Vernaleken","year":"2013","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"10.1016\/j.jad.2014.02.017_bib32","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1192\/bjp.133.5.429","article-title":"A rating scale for mania: reliability, validity and sensitivity","volume":"133","author":"Young","year":"1978","journal-title":"Br. J. Psychiatry"},{"key":"10.1016\/j.jad.2014.02.017_bib33","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1016\/j.biopsych.2011.12.010","article-title":"Replication of ketamine\u05f3s antidepressant efficacy in bipolar depression: a randomized controlled add-on trial","volume":"71","author":"Zarate","year":"2012","journal-title":"Biol. Psychiatry."},{"key":"10.1016\/j.jad.2014.02.017_bib34","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.biopsych.2012.10.019","article-title":"A randomized trial of a low-trapping nonselective N-methyl-d-aspartate channel blocker in major depression","volume":"74","author":"Zarate","year":"2013","journal-title":"Biol. Psychiatry."},{"key":"10.1016\/j.jad.2014.02.017_bib35","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1001\/archpsyc.63.8.856","article-title":"A randomized trial of an N-methyl-d-aspartate antagonist in treatment-resistant major depression","volume":"63","author":"Zarate","year":"2006","journal-title":"Arch. Gen. Psychiatry"}],"container-title":["Journal of Affective Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S016503271400055X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S016503271400055X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,8,7]],"date-time":"2019-08-07T14:59:57Z","timestamp":1565189997000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S016503271400055X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,4]]},"references-count":35,"alternative-id":["S016503271400055X"],"URL":"https:\/\/doi.org\/10.1016\/j.jad.2014.02.017","relation":{},"ISSN":["0165-0327"],"issn-type":[{"value":"0165-0327","type":"print"}],"subject":[],"published":{"date-parts":[[2014,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Do the dissociative side effects of ketamine mediate its antidepressant effects?","name":"articletitle","label":"Article Title"},{"value":"Journal of Affective Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jad.2014.02.017","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}